MODEL ONCOLOGY, LLC
Raised
$11M
Investors
30
Min Invest
$100,000
AltStreet Analysis
·Generated from EDGAR primary sources
Model Oncology, LLC is a Delaware-organized entity that filed a Form D on 2026-10-19 reporting $10.9M raised from 30 investors under the Rule 506(b) exemption, with a $100K minimum investment in equity securities. No first sale date, industry group, or parent platform is disclosed in the filing, and the entity does not appear linked to any other known fund family.
This filing sits in the alternative_investment category as a 506(b) private placement with a moderate institutional-style minimum ($100K) and an average check size (~$363K) consistent with accredited/institutional investor participation rather than retail syndication. The $10.9M raise across 30 investors and equity structure is typical of an early-stage operating company or single-purpose capital raise rather than a diversified multi-fund platform.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
In the Terminal
Filing events
2
latest Oct 19, 2026
Critical / warning
0 / 0
0 watch · 2 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
2
raising, closed
Latest event New filer · Oct 19, 2026
SEC.govInvestor
- 2 filing events with values and deltas, latest 2026-10-19, and alerts on the next one
- 2 offering timelines: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Item 3 changed on the Form D filed 2026-10-19: 3 related persons added and 0 removed against the filing of 2024-12-30; 9 now listed. The names are in the Terminal feed.
THOMAS HARPER, JR.
Executive Officer, Promoter · NASHVILLE, TN
DAVID CHERNOW
Executive Officer, Director · NASHVILLE, TN
ROBERT ORTENZIO
Director · NASHVILLE, TN
MARTIN JACKSON
Director · NASHVILLE, TN
WILLIAM DOWNEY
Director · NASHVILLE, TN
STANLEY MARKS, MD
Director · NASHVILLE, TN
MAX BUETOW
Director · NASHVILLE, TN
PHILLIP WATTS
Promoter · NASHVILLE, TN
STEVEN CUTLER
Promoter · NASHVILLE, TN
Questions About MODEL ONCOLOGY, LLC
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is MODEL ONCOLOGY, LLC?
MODEL ONCOLOGY, LLC is a Delaware limited liability company organized in 2024 that filed a Form D with the SEC on October 19, 2026 in the Other Health Care industry group. The filing claims Rule 506(b) for an offering of equity.
Is MODEL ONCOLOGY, LLC legit?
AltStreet does not rate legitimacy; it reports the public record. MODEL ONCOLOGY, LLC filed a Form D with the SEC on October 19, 2026 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $10,915,000 sold to 30 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is MODEL ONCOLOGY, LLC registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that MODEL ONCOLOGY, LLC claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has MODEL ONCOLOGY, LLC raised?
MODEL ONCOLOGY, LLC reported $10,915,000 sold from 30 investors of a $17,500,000 total offering as of the Form D filed October 19, 2026.
Who can invest in MODEL ONCOLOGY, LLC?
The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $100,000.
What is the minimum investment in MODEL ONCOLOGY, LLC?
The Form D lists $100,000 as the minimum investment accepted from any outside investor as of October 19, 2026. Issuers can waive their own minimums, and the figure does not include fees.
Who is selling MODEL ONCOLOGY, LLC and how are they paid?
The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates.
Who is behind MODEL ONCOLOGY, LLC?
The Form D lists 9 related persons: THOMAS J. HARPER, JR., executive officer, promoter; DAVID S. CHERNOW, executive officer, director; ROBERT A. ORTENZIO, director; MARTIN F. JACKSON, director; WILLIAM B. DOWNEY, director; STANLEY M. MARKS, MD, director; MAX BUETOW, director; PHILLIP H. WATTS, promoter (Mr. Watts is no longer affiliated with the Issuer, but has served as a promoter within the past 5 years), and 1 more. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is MODEL ONCOLOGY, LLC located?
The issuer's address on its SEC filings is 209 10th Avenue South, Suite 328, Nashville, TN 37203. Its phone number of record is 717-253-5259. It is organized under the laws of Delaware.
How long is the MODEL ONCOLOGY, LLC offering open?
The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open, and no amendment is on record yet.
What is MODEL ONCOLOGY, LLC's revenue?
The issuer declined to disclose its revenue range on the Form D, which the form permits.
Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.